51 – 60 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews
(
- Contribution to journal › Article
-
Mark
The tyranny of the averages and the indiscriminate use of risk factors in public health : The case of coronary heart disease
(
- Contribution to journal › Article
-
Mark
Intersectionality and risk of ischemic heart disease in Sweden: categorical and anti-categorical approaches
2017) IEA World Congress of Epidemiology 2017(
- Contribution to conference › Other
- 2016
-
Mark
Regulating Pharmaceutical Industry Marketing: Development, Enforcement and Outcome of Marketing Rules
(
- Contribution to journal › Article
-
Mark
Unhealthy marketing of pharmaceutical products: An international public health concern
(
- Contribution to journal › Article
-
Mark
Hail the Tattletale
(
- Contribution to specialist publication or newspaper › Newspaper article
- 2015
-
Mark
Många allvarliga brott mot regler när läkemedel marknadsförs
(
- Contribution to journal › Letter
-
Mark
Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
(
- Contribution to journal › Article
-
Mark
Etik och marknadsföring: Skäl till självkritik?
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Replik, etik och marknadsföring: Inte för sent för reformer
(
- Contribution to journal › Letter